Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-21
2000-07-11
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546122, A61K 314375, A61P 910, C07D47104
Patent
active
060873736
ABSTRACT:
A compound which inhibits human thrombin and which has the general structure ##STR1##
REFERENCES:
patent: 4296114 (1981-10-01), Appleton et al.
patent: 5260307 (1993-11-01), Ackermann et al.
patent: 5272158 (1993-12-01), Hartman et al.
patent: 5405854 (1995-04-01), Ackermann et al.
patent: 5459142 (1995-10-01), Tone et al.
patent: 5510369 (1996-04-01), Lumma et al.
patent: 5585385 (1996-12-01), Natsugari et al.
patent: 5602253 (1997-02-01), Antonsson et al.
Semple et al., J. Med. Chem., vol. 39 (1996), pp. 4531-4536, "Design, synthesis, and evolution of a novel, selective, and orally bioavailable class of thrombin inhibitors . . . ".
Bernstein, et al., J. Med. Chem., 37, 3313-3326 "Nonpeptidic Inhibitors of Human Leukocyte Elastase . . . ", 1994.
Temple, Carroll, Jr. and Gregory A. Rener, J. Med. Chem., "Antimitotic Agents: Ring Analogues and Derivatives of Ethyl . . . ", vol. 35, pp. 4809-4812 (1992).
Mack, Helmut et al., J. Enzyme Inhibition, "Design, Synthesis and Biological activity of Novel Rigid . . . , " vol. 9, pp. 73-86 (1995).
Edwards, Philip D. et al., J. American Chemical Soc., "Design, Syntheses, and Kinetic Evaluation of a Unique Class of Elastase Inhibitors . . . , " vol. 114, pp. 1854-1863 (1992).
Brown, Frederick J. et al., J. Med. Chem., "Design of Orally Active, Non-Peptidic Inhibitors of Human Leukocyte Elastase," vol. 37, pp. 1259-1261 (1994).
Coburn Craig
Vacca Joseph P.
Williams Peter D.
Merck & Co. , Inc.
Morris Patricia L.
Parr Richard S.
Winokur Melvin
LandOfFree
Thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-542739